San Diego CA—CBRE has announced that Zack Holderman has joined its Healthcare and Life Science Capital Markets team as a senior vice president. Based at the firm’s San Diego office, Mr. Holderman will focus on the placement of debt and equity for healthcare and life sciences clients nationwide.
Mr. Holderman will join Chris Bodnar and Lee Asher, vice chairmen and co-leaders of CBRE’s Healthcare & Life Sciences Capital Markets team, and will partner with Sabrina Solomiany to enhance the team’s debt and equity placement offering nationally. He will work closely with the local Debt & Structured Finance team comprised of Bill Chiles, Scott Peterson and Mark McGovern.
“Zack is highly respected within our industry and we’re excited to have him as part of the team,” said Mr. Bodnar. “His strong relationships with owners, developers, and capital providers in both life sciences and medical office sectors will be a huge asset to our clients and will complement Sabrina’s relationships in the medical office and acute care space.”
An accomplished commercial real estate finance executive with more than 17 years of experience, Mr. Holderman has an extensive background in structuring financing strategies and negotiating with lenders and equity providers to achieve capital solutions for institutional investors and developer clients across all healthcare and life science asset types.
“Medical office and life sciences have proven to be resilient, both as an industry and asset class, offering a tremendous opportunity for investors. Joining the nation’s leading, healthcare capital markets team is an exciting opportunity to deliver a comprehensive approach to client’s investment needs through this unprecedented time and foreseeable future,” added Mr. Holderman.
Peterson added, “Zack’s capabilities in the medical office and biotech space, along with raising equity capital for his clients, makes him a great addition to our team here in San Diego. We are excited to have someone of his caliber and experience.”
Mr. Holderman spent the last 14 years at HFF, which was acquired by JLL last year, most recently as a senior director for the firm’s Healthcare Capital Markets division. Over the course of his career, he has been involved in more than $6.4 billion of debt, equity placement and investment advisory transactions.